The late Na current as a therapeutic target: where are we?

J Mol Cell Cardiol. 2013 Aug:61:44-50. doi: 10.1016/j.yjmcc.2013.03.001. Epub 2013 Mar 13.

Abstract

In this article we review the late Na current which functionally can be measured using patch-clamp electrophysiology (INa,late). This current is largely enhanced under pathological myocardial conditions such as ischemia and heart failure. In addition, INa,late can cause systolic and diastolic contractile dysfunction via a Na-dependent Ca-overload of the myocyte. Moreover, INa,late plays a crucial role as ventricular and atrial proarrhythmic substrate in myocardial pathology by changing cellular electrophysiology. We summarize recent experimental and clinical studies that investigate therapeutic inhibition of this current and discuss the significance of the available data and try to answer not only the question, where we currently are but also where we may go in the near future. This article is part of a Special Issue entitled "Na(+) Regulation in Cardiac Myocytes".

Keywords: Angina; Arrhythmias; Heart failure; I(Na,late); Ischemia; Ranolazine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / metabolism
  • Arrhythmias, Cardiac / physiopathology
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / physiopathology
  • Calcium / physiology
  • Heart Failure / drug therapy
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Humans
  • Myocardial Contraction
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / physiopathology
  • Myocardium / metabolism
  • Sodium Channel Blockers / pharmacology*
  • Sodium Channel Blockers / therapeutic use

Substances

  • Sodium Channel Blockers
  • Calcium